Another way to protect the IP of a process innovation is to turn the process into a product. One inventor team linked to our TTO came up with a method for studying stem cells in vitro while simulating conditions similar to those in vivo. Although the commercial applications for researchers and biotechnology firms were immediately apparent, it was equally clear that it would be hard to police unlicensed use of the technology. The inventors’ solution was to turn the method into a kit that could be sold as a product. With a diagnostic product readily available, users would have little incentive to make their own devices.